Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Specialty chemicals company Albemarle Corporation ( ALB - Snapshot Report ) declared that its joint venture, Jordan Bromine Company (JBC), has successfully commissioned the first phase of its earlier-announced expansion project. The phase doubles the bromine production capacity of the site. The investment reinforces JBC’s position as the world's low-cost bromine producer.
The successful startup is attributed to the skill of JBC’s teams and implementation of technology that boosts bromine capacity. The investment enables JBC to provide quality products to its customers globally.
This project is a testimony of JBC’s commitment to safe and sustainable operations and will also help in new job creation. The significant capital expansion explains Jordan's powerful economic potential and prosperity of the region.
JBC, situated on the Dead Sea in Safi, Jordan, is a joint venture between Arab Potash Company and Albemarle Holding Company, Limited, a fully-owned subsidiary of Albemarle. The commissioning of the second phase of expansion project has been scheduled in May 2013. The second phase of the expansion is set to double the current capacity of bromine derivatives, hydrobromic acid, calcium bromide and sodium bromide.
Albemarle, a global leader in the development, manufacture and marketing of bromine, bromine derivatives and other specialty chemicals, reported fourth-quarter 2012 adjusted earnings of $1.17 a share compared with $1.13 per share earned in the year-ago quarter.
Revenues were $687.6 million in the quarter, down 4% from $707.4 million in the year-ago quarter. Sales were impacted by lower metal surcharges in the Catalysts segment, more than offsetting volume growth.
Albemarle’s exit from the phosphorus business, absence of pension obligations, its strong balance sheet and investments for future growth are expected to benefit the company, going forward.
Albemarle currently retains a Zacks Rank #3 (Hold).
Air Products & Chemicals Inc. ( APD - Analyst Report ) , Axiall Corporation ( AXLL - Snapshot Report ) and LyondellBasell Industries ( LYB - Snapshot Report ) also belong to the diversified chemical industry. Each of them holds a Zacks Rank #2 (Buy).
Read the full reports :
Analyst Report on APD
Snapshot Report on ALB
Snapshot Report on LYB
Snapshot Report on AXLL